Cargando…

Fibrosis‑4 (FIB‑4) index and mortality in COVID‑19 patients admitted to the emergency department: a new interesting predictive index for patients with COVID-19 disease?

Detalles Bibliográficos
Autores principales:	Ruggeri, Paolo, Esquinas, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Ce - Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374285/ https://www.ncbi.nlm.nih.gov/pubmed/35962270 http://dx.doi.org/10.1007/s11739-022-03067-w

Ejemplares similares

Fibrosis-4 (FIB-4) Index and mortality in COVID-19 patients admitted to the emergency department
por: Bucci, Tommaso, et al.
Publicado: (2022)

Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
por: Li, Yijia, et al.
Publicado: (2020)

Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization
por: Gabrielli, Maurizio, et al.
Publicado: (2021)

Repurposing FIB-4 index as a predictor of mortality in patients with hematological malignancies and COVID-19
por: Sutandyo, Noorwati, et al.
Publicado: (2021)

Hospital mortality and failure of non-invasive ventilation in COVID-19: looking inside the predictive scores
por: Piazza, Isabelle, et al.
Publicado: (2022)

Fibrosis-4 (FIB-4) index as a predictor for mechanical ventilation and 30-day mortality across COVID-19 variants
por: Parajuli, Priyanka, et al.
Publicado: (2023)

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients
por: Metwally, Khaled, et al.
Publicado: (2020)

Delirium in COVID‑19 pneumonia: looking inside the geriatric unit
por: Vargas, Nicolas, et al.
Publicado: (2022)

Derivation of age-adjusted LACE index thresholds in the prediction of mortality and frequent hospital readmissions in adults
por: Fry, Christopher Henry, et al.
Publicado: (2020)

Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting
por: Blanco-Grau, Albert, et al.
Publicado: (2021)

Not so mild: emergency department utilization after index COVID infection stratified by disease severity
por: Bastani, Aveh, et al.
Publicado: (2022)

High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?
por: Cameli, Paolo, et al.
Publicado: (2021)

Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)

Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study
por: Nazerian, Peiman, et al.
Publicado: (2021)

Atypical manifestations of COVID-19: to know signs and symptoms to recognize the whole disease in the Emergency Department
por: Pagliari, Danilo, et al.
Publicado: (2021)

Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer
por: Tralongo, Antonino Carmelo, et al.
Publicado: (2022)

COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine
por: Polosa, Riccardo, et al.
Publicado: (2020)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
por: Huang, Dedong, et al.
Publicado: (2019)

Acquired COVID-19 infection in the Emergency Department after its reorganization during the pandemic: single center prospective study
por: Nazerian, Peiman, et al.
Publicado: (2020)

Lung ultrasound presentation of covid-19 patients: phenotypes and correlations—comment
por: Nekludova, Galina, et al.
Publicado: (2021)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

The burden of thrombotic complications in critically ill patients with COVID-19: charting the uncharted
por: Landi, Antonio, et al.
Publicado: (2020)

Two different patterns of lymphocyte alterations in critically ill COVID-19 patients
por: Lafarge, Antoine, et al.
Publicado: (2021)

COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder
por: Tamburin, Stefano, et al.
Publicado: (2021)

Incidence and outcome of delirium during helmet CPAP treatment in COVID-19 patients
por: Samartin, Federica, et al.
Publicado: (2021)

Do error rates change in the emergency department when patient volume decreases: the effect of COVID-19 on ED error
por: Grossman, Elianna S., et al.
Publicado: (2022)

Ethics in the age of COVID-19
por: Arora, Ananya, et al.
Publicado: (2020)

COVID-19: thoughts at sunrise
por: Gasbarrini, Giovanni
Publicado: (2020)

COVID-19 vaccines and thrombosis
por: Famularo, Giuseppe
Publicado: (2021)

Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients
por: Demir, Münevver, et al.
Publicado: (2016)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
por: Seko, Yuya, et al.
Publicado: (2020)

The Diagnostic Value of the FIB-4 Index for Staging Hepatitis B-Related Fibrosis: A Meta-Analysis
por: Li, Yuanyuan, et al.
Publicado: (2014)

Camostat mesilate therapy for COVID-19
por: Uno, Yoshiharu
Publicado: (2020)

Prevalence and Prognostic Importance of High Fibrosis-4 Index in COVID-19 Patients
por: Demir, Nurhan, et al.
Publicado: (2022)

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients
por: Bazzan, Mario, et al.
Publicado: (2020)

SIADH and severe COVID-19 pneumonia in elderly patients: a therapeutic challenge in developing countries
por: Concepción Zavaleta, Marcio Jose, et al.
Publicado: (2021)

Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment
por: Rossio, Raffaella, et al.
Publicado: (2021)

Monitoring COVID-19 patients in an internal medical ward: chest radiography, chest CT or POCUS?
por: Flor, Nicola, et al.
Publicado: (2021)

Emergency department visits and readmissions after COVID-19 hospitalization: a cross-sectional analysis
por: Gwin, Mary, et al.
Publicado: (2021)

Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients
por: Li, Xu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6rbkoc8c1t2jf2absesrl1jqun